Evidence map›Paper›PMID 35262876›Full record

ArticleMolecular biotechnology2022

CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells.

Xiaowen Yang, Shilin Zhou, Chunyue Yang, Chunyan Cao, Meijun He, Shuxia Zi

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. [Screening and validation of pivotal genes in hepatitis B virus-associated hepatocellular carcinoma].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xiaowen YangDepartment of Gynaecology and Obstetrics, Joint Service Support Force No.920 Hospital of the PLA, No. 212 Daguan Road, Xishan District, Kunming, 650032, Yunnan Province, China.ORCID http://orcid.org/0000-0001-6303-8426
Shilin ZhouDepartment of Gynaecology and Obstetrics, Joint Service Support Force No.920 Hospital of the PLA, No. 212 Daguan Road, Xishan District, Kunming, 650032, Yunnan Province, China.
Chunyue YangDepartment of Gynaecology and Obstetrics, Joint Service Support Force No.920 Hospital of the PLA, No. 212 Daguan Road, Xishan District, Kunming, 650032, Yunnan Province, China. 64374504@qq.com.
Chunyan CaoDepartment of Gynaecology and Obstetrics, Joint Service Support Force No.920 Hospital of the PLA, No. 212 Daguan Road, Xishan District, Kunming, 650032, Yunnan Province, China.
Meijun HeDepartment of Gynaecology and Obstetrics, Joint Service Support Force No.920 Hospital of the PLA, No. 212 Daguan Road, Xishan District, Kunming, 650032, Yunnan Province, China.
Shuxia ZiDepartment of Gynaecology and Obstetrics, Joint Service Support Force No.920 Hospital of the PLA, No. 212 Daguan Road, Xishan District, Kunming, 650032, Yunnan Province, China.
People's Liberation Army 401 Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclin B1 (CCNB1) is regarded as an oncogene in multiple tumors. This work aims to investigate the expression, function, and related mechanisms of CCNB1 in ovarian carcinoma (OC). Three microarray datasets (GSE14407, GSE18520, and GSE54388) were obtained from the Gene Expression Omnibus (GEO) database and screened for differentially expressed genes (DEGs) of OC tissues and normal ovarian tissues. CCNB1 expression in OC tissues and paracancerous tissues was detected by immunohistochemistry. Kaplan-Meier plotter database was utilized to analyze the correlation between CCNB1 expression and the prognosis of OC patients. After the loss-of-function and gain-of-function cell models were established, cell counting kit-8 (CCK-8), bromo-deoxyuridine (BrdU), and transwell experiments were employed to examine the proliferation, migration, and invasion of OC cells, respectively. The targeting relationship between miR-559 and CCNB1 was verified using the dual-luciferase reporter gene experiment. The expressions of CCNB1 mRNA and miR-559 were detected by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Western blot was used to quantify the protein expression of CCNB1. In addition, xenograft nude mouse models were established to examine the effects of CCNB1 on lung metastasis in vivo. CCNB1 expression was markedly increased in OC tissues and cell lines. The overall survival, progression-free survival, and post-progression survival of OC patients with high CCNB1 expression were significantly shorter. OC cell proliferation, migration, and invasion were enhanced by CCNB1 overexpression while CCNB1 knockdown led to opposite effects. MiR-559 expression was remarkably reduced in OC tissues and cell lines, and miR-559 markedly suppressed the malignant characteristics of OC cells. Besides, miR-559 directly targeted the 3' UTR of CCNB1 mRNA and reduced CCNB1 expression at both the mRNA and protein levels. Overexpression of CCNB1 accelerated lung metastasis of OC cells in vivo. CCNB1, of which expression is modulated by miR-559, facilitates proliferation, migration, and invasion of OC cells, therefore, working as a potential therapeutic target of OC. This work provides new insights into the clinical diagnosis and treatment of OC.

Indexed as

Lung NeoplasmsMicroRNAsOvarian Neoplasms3' Untranslated RegionsAnimalsCell Line, TumorCell MovementCell ProliferationCyclin B1FemaleGene Expression Regulation, NeoplasticHumansMice3' Untranslated RegionsCCNB1 protein, humanCyclin B1MicroRNAsMIRN559 microRNA, humanCCNB1miR-559Ovarian carcinoma

Identifiers

PMID35262876
OpenAlexW4220941905

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.